FDA Approves Medtronic’s VenaSeal To Treat Venous Reflux
This article was originally published in The Gray Sheet
Executive Summary
VenaSeal was developed by Sapheon Inc., which Covidien acquired in the summer of 2014 shortly after it announced plans to merge with Medtronic.